Abstract
The effects of bromocriptine (CB-154, 2.5 mg po), clonidine (0.05 mg im) and naloxone (0.4 mg im), as well as the interaction between naloxone and CB-154 or clonidine on basal insulin secretion were studied in 6 normal men. Clonidine, naloxone and CB-154 plus naloxone lowered insulin plasma levels; CB-154 alone caused only a slight reduction, whereas clonidine plus naloxone did not affect insulin secretion. These results prove the existence of a complex neuroendocrine control of basal insulin secretion through dopaminergic, adrenergic and opiate mechanisms; they also suggest that the opiate inhibitory control of insulin release may be dissociated from the dopaminergic one, but may interact with the adrenergic one.
Similar content being viewed by others
References
Gerich J.E., Lorenzi M. The role of the autonotic nervous system and somatostatin in the control of insulin and glucagon secretion. In: Ganong W.F., Martini L (Eds.), Frontiers in neuroendo-crinology. Raven Press, New York, 1978, vol. 5, p. 265.
Smith P.H., Porte D. Neuropharmacology of the pancreatic islets. Annu. Rev. Pharmacol. Toxicol. 16: 269, 1976.
Smith P.H., Woods S.C., Porte D. Jr. Control of the endocrine pancreas by the autonomic nervous system and related neural factors. In: Brooks C., Koizumi K., Sato A. (Eds.), Integrative functions of the autonomic nervous system. University of Tokyo Press, Tokyo, 1979, p. 84.
Woods S., Porte D. Neural control of the endocrine pancreas. Physiol. Rev. 54: 596, 1974.
Gerich J.E. Somatostatin and the endocrine pancreas. In: Labrie F., Meites J., Pellitier G. (Eds.), Current topics in molecular endocrinology: hypothalamus and endocrine function. Plenum Press, New York, 1976, vol. 3, p. 127.
Cegrell L. The occurrence of biogenic monoamines in the mammalian endocrine pancreas. Acta Phys. Scand. (Suppl. 314) 74: 1, 1968.
Polak J.M., Sullivan S.N., Bloom S.R., Facer P., Pearse A.G.E. Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet: 972, 1977.
Cerasi E., Luft R., Efendic S. Antagonism between glucose and epinephrine regarding insulin secretion: a dose-response study in man. Acta Med. Scand. 190: 411, 1971.
Gagliardo J., Bellone C., Doha I., Sanchez J., Pereyra V. Adrenergic regulation of basal serum glucose, NEFA and insulin levels. Horm. Metab. Res. 2: 318, 1970.
Imura H., Kato Y., Ikeda M., Moumoto M., Yawata M. Effects of adrenergic blocking or stimulating agents on plasma growth hormone, immunoreactive insulin and blood free fatty acid levels in man. J. Clin. Invest. 50: 1069, 1971.
Quickel K., Feldman J.M., Lebovitz H.E. Inhibition of insulin secretion by serotonin and dopamine: species variation. Endocrinology 89: 1295, 1971.
Feldman J.M., Boyd A.E. III, Lebovitz H.E. Structural determinants of catecholamine action on in vitro insulin release. J. Pharmacol., Exp. Ther. 176: 611, 1971.
Wilson J.P., Downs R.W., Feldman J.M., Lebovitz H.E. Beta cell monoamines: further evidence for their role in modulating insulin secretion. Am. J. Physiol. 227: 305, 1974.
George D.T., Rayfield E.J. L-dopa induced plasma glucagon release. J. Clin. Endocrinol. Metab. 39: 618, 1974.
Rayfield E.J., George D.T., Eichner H.L., Hsu T.H. L-dopa stimulation of glucagon secretion in man. N. Engl. J. Med. 293: 589, 1975.
Leblanc H., Lachelin G.C.L., Abu-Fadil S., Yen S.S.C. The effect of dopamine infusion on insulin and glucagon secretion in man. J. Clin. Endocrinol. Metab. 44: 196, 1977.
Lorenzi M., Karam J.H., Tsalikian E., Bohannon N.V., Gerich J.E., Forsham P.H. Dopamine during α- or β-adrenergic blockade in man. J. Clin. Invest. 63: 310, 1979.
Ipp. E., Dobbs R., Unger R.H. Morphine and/3-endorphin influence the secretion of the endocrine pancreas. Nature 276: 190, 1978.
Kanter R.A., Ensinck J.W., Fujimoto W.Y. Disparate effects of enkephalin and morphine upon insulin and glucagon secretion by islet cell cultures. Diabetes 29: 84, 1980.
Tojota T., Ikeda M., Kai Y., Miura M., Goto Y. Effects of the Met-enkephalin on the release of insulin and glucagon. 6th International Congress of Endocrinology, Melbourne 1980, p. 595, (Abstract 771).
Ryder S., Murthy Gollapudi G., Ryder D. Morphine sulfate inhibits insulin release from isolated, superfused rat pancreatic islets. Horm. Metab. Res. 12: 412, 1980.
Green I.C., Perrin D., Pedley K.C., Leslie R.D.G., Pyke D.A. Effect of enkephalins and morphine on insulin secretion from isolated rat islets. Diabetologia 79: 158, 1980.
Stubbs W.A., Jones A., Edwards C.R.W., Delitala G., Jeffcoate W.J., Ratter S.J., Besser G.M., Bloom S.R., Alberti K.G.M.M. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 2: 1225, 1978.
Martin W.R. Naloxone. Ann. Intern. Med. 85: 765, 1976.
Fuxe K., Fredholm B.B., Ogren S.O., Agnati L.F., Hokfelt T., Gustaffson J.A. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine. Acta Endocrinol. (Kbh.) (Suppl. 216) 88: 27, 1978.
Struyker Boudier H., Smeets G., Brouwer G., van Rossum J. Central and peripheral alpha adrenergic activity of im idazoline derivatives. Life Sci. 15: 887, 1974.
Hales C.N., Randle P.J. Immunoassay of insulin with insulin antibody precipitate. Biochem. J. 88: 137, 1963.
Hugget A.S.G., Nixon D.A. Use of glucose oxidase, peroxidase and o-dianisidine in determination of blood and urinary glucose. Lancet 2: 368, 1957.
Dunnet C.W. New tables for multiple comparisons with a control. Biometrics 20: 482, 1964.
Duncan D.B. Multiple range and multiple F tests. Biometrics 11: 1, 1955.
Kirk R.E. tExperimental design procedures for the behavioural sciences. Brooks-Cole Publ. Co., Belmont, California, 1968.
Ungerstedt U. The role of dopamine as a neurotransmitter in the central and the autonomic nervous system. Acta Endocrinol. (Kbh.) (Suppl. 216) 88: 13, 1978.
Lundberg J.M., Hokfelt T., Nilsson G., Terenius L., Rehfeld J., Elde R., Said S. Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol. Scand. 104:499, 1978.
Metz S.A., Halter J.B., Robertson R.P. Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Diabetes 27: 554, 1978.
Gerich J.E., Langlois M., Noacco C., Schneider V., Forsham P.H. Adrenergic modulation of pancreatic glucagon secretion in man. J. Clin. Invest. 53: 1441, 1974.
Rand M.G., Majewski H., Medgett I.C., McCulloch M.W., Story D.F. Prejunctionaf receptors modulating autonomic neuroef-fector transmission. Circ. Res. (Suppl. 1) 46: 70, 1980.
Metz S., Halter J.B., Porte D. Jr., Robertson R.P. Suppression of plasma catecholamines and flushing by clonidine in man. J. Clin. Endocrinol. Metab. 46: 83, 1978.
Hope W., Majewski H., McCulloch M.W., Rand M.J., Story D.F. Evidence for a modulatory role of dopamine in sympathetic transmission. Circ. Res. (Suppl. 1) 46: 77, 1980.
Starke K. Presynaptic receptors and the control of noradrenaline release. Trends Pharmacol. Sci. 1: 268, 1980.
Carrvanni F., Massara F., Belforte L., Molinatti G.M. Changes inplasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-α-ergocryptine. J. Clin. Endocrinol. Metab. 40: 363, 1975.
Agnati L.F., Benfenati F., Cortelli P., D’Alessandro R., Ghisoli E., Zampa G.A. A study on the effect of interaction between naloxone and 2-Br-α-ergocryptine or clonidine on luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone in normal man serum. Neurosci. Lett. 12: 307, 1979.
Lorenzi M., Tsalikian E., Bohannon N.V., Gerich J.E., Karam J.H., Forsham P.H. Differential effects of L-dopa and apomorphine on glucagon secretion in man. J. Clin. Endocrinol. Metab. 45: 1154, 1977.
Schwartz J.C. Opiate receptors on catecholaminergic neurones in brain. Trends Neurosci. 2:137, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zampa, G.A., Benfenati, F., Ghisoli, E. et al. Neuroendocrine control of basal insulin secretion in man: a study with bromocriptine, clonidine and naloxone. J Endocrinol Invest 4, 423–429 (1981). https://doi.org/10.1007/BF03348306
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348306